agForce, Germany, will increase its company‘s share capital from EUR4,127,041 up to

EUR4,952,449 through the partial utilization of its existing authorized capital of up to EUR825,408 newly registered common shares with no par value common with a nominal value of EUR1.00 per share against cash contributions. The company will offer its shareholders the right to subscribe new shares at a ratio of 5:1 (indirect subscription right). The subscrip- tion period begins for shareholders on Friday, Febru- ary 3, 2012 and will run for two weeks through Fe- bruary 16, 2012. The subscription price is EUR5.50. The rights offering for shareholders were published on Thursday, February 2, 2012.

MagForce AG is a leader in the area of nanotechno- logy-based cancer treatment, and the first compa- ny worldwide to receive European approval for a medical product using nanoparticles. The novel therapy is available to patients at the NanoTherm® therapy center in Germany.

embrana-Charlotte, a Division of Celgard, launched a new online store for memb-

rane contactors. The store expands the company’s existing internet presence while also providing customers with a convenient channel to purchase Liqui-Cel® Module®

, SuperPhobic® , MiniModule® degasification products.

Moreover, many high-speed, wide-format ink jet printer manufacturers are now using SuperPhobic® Membrane Contactors to remove air bubbles and excess gasses from the ink feeding the print head to reduce downtime and improve yields. Membrana has developed several small membrane contactors designed specifically for Ink debubbling. These Membrane contactors utilize a unique nonporous membrane that is gas permeable.

Membrana-Charlotte is a Division of Celgard, and is a POLYPORE Company (NYSE: PPO). Polypore International, Inc. is a global high technology filtrati- on company specializing in microporous membranes. Polypore‘s flat sheet and hollow fiber membranes are used in specialized applications that require the re- moval or separation of various materials from liquids, primarily in the ultrafiltration and microfiltration markets.